Stocks and Investing Stocks and Investing
Wed, November 13, 2019
Tue, November 12, 2019
Mon, November 11, 2019
Fri, November 8, 2019
Thu, November 7, 2019

Andrew Mok Maintained (AMED) at Hold with Increased Target to $154 on, Nov 7th, 2019


Published on 2024-10-26 17:58:04 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $144 to $154 on, Nov 7th, 2019.

Andrew has made no other calls on AMED in the last 4 months.



There are 4 other peers that have a rating on AMED. Out of the 4 peers that are also analyzing AMED, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $145 on, Tuesday, October 22nd, 2019


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Whit Mayo of "Baird" Upgraded from Hold to Buy on, Friday, November 1st, 2019
  • Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $155 on, Tuesday, September 17th, 2019
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $144 on, Monday, July 15th, 2019